SAB Biotherapeutics (SABS) Prepaid Assets (2020 - 2026)

SAB Biotherapeutics' Prepaid Assets history runs 7 years deep, the most recent figure standing at $3.8 million for Q1 2026.

• Quarterly Prepaid Assets rose 11.98% year-over-year to $3.8 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $3.8 million (up 11.98% YoY) and the FY2025 annual result came in at $3.5 million, up 18.03% from the prior year.
• Prepaid Assets was $3.8 million for Q1 2026 at SAB Biotherapeutics, up from $3.5 million in the prior quarter.
• Across five years, Prepaid Assets topped out at $3.8 million in Q1 2026 and bottomed at $702231.0 in Q3 2023.
• A 5-year average of $2.2 million and a median of $2.0 million in 2024 frame the typical range for Prepaid Assets.
• Annual changes were most pronounced in 2022 — Prepaid Assets jumped 1038.56% — and 2023, when it sank 59.57%.
• SAB Biotherapeutics' Prepaid Assets stood at $1.5 million in 2022, then jumped by 56.68% to $2.3 million in 2023, then grew by 27.16% to $3.0 million in 2024, then gained by 18.03% to $3.5 million in 2025, then climbed by 9.17% to $3.8 million in 2026.
• Business Quant data shows SABS's Prepaid Assets at $3.8 million in Q1 2026, $3.5 million in Q4 2025, and $1.8 million in Q3 2025.